Friday the FDA approved the first of new class of HIV drugs that may help patients who have the drug resistant form of the virus.
It's called Isentress and it works by blocking genetic material in the virus from entering human DNA. By doing that, it prevents the HIV from duplicating itself. It's part of a class of drugs called integrase inhibitors.
Isentress will come in a pill form that's taken twice per day, and will need to be prescribed as part of a regime of HIV medications. Isentress is made by Merck and Company. The generic name for the drug is Raltegravir.